# OnCo record paper-nct04665856-j-thorac-oncol-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct04665856-j-thorac-oncol-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct04665856-j-thorac-oncol-2026" ;
  schema:name "SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage SCLC in China"@en ;
  schema:description "Published report from the SKYSCRAPER-02C trial registered as NCT04665856, in Journal of Thoracic Oncology (2026), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct04665856-j-thorac-oncol-2026/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.jtho.2026.103713>, <https://pubmed.ncbi.nlm.nih.gov/41950998/>, <https://europepmc.org/article/MED/41950998>, <https://clinicaltrials.gov/study/NCT04665856> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.jtho.2026.103713> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Lu S, Fang J, Yu Y, et al." ;
  onco:trials <https://onco.cc/trials/nct04665856/> ;
  onco:journals <https://onco.cc/journals/journal-of-thoracic-oncology/> .